A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
Public ClinicalTrials.gov record NCT01056315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Trial to Assess the Analgesic Efficacy and Safety of a New Analgesic Compared to Placebo in Subjects With Painful Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is assessing the analgesic efficacy and safety of a new central analgesic in subjects with pain due to diabetic peripheral neuropathy (DPN).
Study identification
- NCT ID
- NCT01056315
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 553 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Oct 28, 2019
2009 – 2011
United States locations
- U.S. sites
- 61
- U.S. states
- 19
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 127 | Fairhope | Alabama | — | — |
| Site 130 | Homewood | Alabama | — | — |
| Site 112 | Tucson | Arizona | — | — |
| Site 129 | Escondido | California | — | — |
| Site 209 | Fullerton | California | — | — |
| Site 135 | Long Beach | California | — | — |
| Site 202 | Northridge | California | — | — |
| Site 208 | Northridge | California | — | — |
| Site 219 | Northridge | California | — | — |
| Site 203 | San Francisco | California | — | — |
| Site 116 | Santa Ana | California | — | — |
| Site 118 | Santa Ana | California | — | — |
| Site 121 | Santa Ana | California | — | — |
| Site 133 | Santa Ana | California | — | — |
| Site 126 | Vista | California | — | — |
| Site 214 | Vista | California | — | — |
| Site 201 | Waterbury | Connecticut | — | — |
| Site 136 | Deerfield Beach | Florida | — | — |
| Site 137 | Deerfield Beach | Florida | — | — |
| Site 140 | Deerfield Beach | Florida | — | — |
| Site 216 | Deerfield Beach | Florida | — | — |
| Site 217 | Deerfield Beach | Florida | — | — |
| Site 218 | Deerfield Beach | Florida | — | — |
| Site 117 | Fort Myers | Florida | — | — |
| Site 124 | Jacksonville | Florida | — | — |
| Site 228 | Jupiter | Florida | — | — |
| Site 101 | Orlando | Florida | — | — |
| Site 226 | Orlando | Florida | — | — |
| Site 206 | Sarasota | Florida | — | — |
| Site 212 | West Palm Beach | Florida | — | — |
| Site 142 | Atlanta | Georgia | — | — |
| Site 128 | Chicago | Illinois | — | — |
| Site 223 | Chicago | Illinois | — | — |
| Site 114 | Leawood | Kansas | — | — |
| Site 102 | Paducah | Kentucky | — | — |
| Site 211 | Baltimore | Maryland | — | — |
| Site 108 | East Bridgewater | Massachusetts | — | — |
| Site 113 | Las Vegas | Nevada | — | — |
| Site 122 | Princeton | New Jersey | — | — |
| Site 230 | New York | New York | — | — |
| Site 109 | Rochester | New York | — | — |
| Site 225 | Asheville | North Carolina | — | — |
| Site 115 | High Point | North Carolina | — | — |
| Site 227 | Canton | Ohio | — | — |
| Site 233 | Cincinnati | Ohio | — | — |
| Site 111 | Toledo | Ohio | — | — |
| Site 125 | Toledo | Ohio | — | — |
| Site 104 | Philadelphia | Pennsylvania | — | — |
| Site 106 | Philadelphia | Pennsylvania | — | — |
| Site 205 | Philadelphia | Pennsylvania | — | — |
| Site 105 | Austin | Texas | — | — |
| Site 213 | Corpus Christi | Texas | — | — |
| Site 110 | Houston | Texas | — | — |
| Site 123 | Houston | Texas | — | — |
| Site 204 | Houston | Texas | — | — |
| Site 210 | Houston | Texas | — | — |
| Site 231 | Houston | Texas | — | — |
| Site 131 | San Antonio | Texas | — | — |
| Site 215 | San Antonio | Texas | — | — |
| Site 221 | San Antonio | Texas | — | — |
| Site 139 | Provo | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01056315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2019 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01056315 live on ClinicalTrials.gov.